Company Overview

Development Stage

  • Stage: IPO上市, 。
  • Ranking: Ranked #33 in Weihai by popularity Ranked #2 in Weihai医疗器械公司 by popularity
  • Honors: 驰名商标 高新技术企业 According to algorithm
  • Salary: 51.7% of positions earn 10-20K, In 2026 vs last yeargrew by 1%.。Master's salary: ¥13.2K.
  • R&D: "医疗卫生/美容保健类" demand: 20.7%, "其他(研发和技术类)": 19%, "计算机/网络/技术类": 10.3%。
  • Recruiting: In 2026 vs 2025decreased by 13%. Demand for highly educated talent: Master's: 5.
  • Requirement: Education: 本科 leads with 53.2%. Experience: 3-5年 leads with 32.3%.
  • Region: Distributed across 3 regions, 威海: 67.7%, 上海: 11.3%, 赣州: 9.7%, 南京: 3.2%.

About the Company

[Summary] 液净化治疗相关的产品与服务

威高血液净化产业集团成立于2004年,专注血液净化领域,服务国内近3500家客户,凭借技术与品质逐渐成为实力雄厚的国际化产业集团。集团下辖六家子公司,携手泰尔茂和日机装两大国际医疗企业,以血液透析、腹膜透析和透析服务三大业务为战略发展方向,实现了血液净化治疗相关的产品与服务全产业链覆盖,尽心服务全球肾病患者。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

威高血液净化 Financing History (3 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal:

威高血液净化 How Fast Is Hiring Growing? (3 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 14%
  • 2024: Down 46%
  • 2023: Down 11%
  • 2022: Up 46%
威高血液净化 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
威高血液净化 Campus Recruitment & Advanced Degree Talent Demand
Graduates 1 Master's 5
Note: How fast is hiring at 山东威高血液净化制品股份有限公司 growing? 威高血液净化2026: 35 openings (down 13%), 2025: 40 openings (up 14%), 2024: 35 openings (down 46%), 2023: 65 openings (down 11%), 2022: 73 openings (up 46%), 2021: 50 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

威高血液净化 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 15%
  • 2024: Down 38%
  • 2023: Down 9%
  • 2022: Up 283%
威高血液净化 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 山东威高血液净化制品股份有限公司 growing? 威高血液净化Master's recruitment over the years: 2025: 11 openings (down 15%), 2024: 13 openings (down 38%), 2023: 21 openings (down 9%), 2022: 23 openings (up 283%), 2021: 6 openings.

威高血液净化 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 山东威高血液净化制品股份有限公司? Based on an analysis of 威高血液净化's job postings over the past year, "医疗卫生/美容保健类" demand: 20.7%, "其他(研发和技术类)": 19%, "计算机/网络/技术类": 10.3%, "机械/仪器仪表类": 6.9%, "生物/制药/化工/环保类": 3.4%, "电子/电器/通信技术类": 3.4%. For reference only.

威高血液净化 — What Are the Salaries Like? (58 records)

Manage
salary range: 4.5K - 20K, 51.7% of roles pay ¥10-20K
Note: salary statistics are based on 58 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 山东威高血液净化制品股份有限公司?威高血液净化51.7% of positions earn 10-20K, Fresh graduate salary: ¥5.3K。Weihai salary ranking top 30,销售类 average salary ¥9.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 威高血液净化

(More)
Are salaries high at 山东威高血液净化制品股份有限公司? We provide: 销售,研发工程师,储备管理,医疗器械,注册专员,软件工程,ie,品质部,嵌入式,工艺工程,开发工程师,技术支持,操作工,材料研发,测试工程,电工,精益工程师,结构工程,维修工,设备维修. Click to view detailed salary analysis by job.

威高血液净化 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

威高血液净化 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 销售类
    21% of total 21%
  • 医疗卫生/美容保健类
    19.4% of total 19.4%
  • 其他(研发和技术类)
    17.7% of total 17.7%
  • 技工类
    14.5% of total 14.5%

Education

  • 本科
    53.2% of total 53.2%
  • 硕士
    30.6% of total 30.6%
  • 大专
    8.1% of total 8.1%
  • 高中
    3.2% of total 3.2%

Experience

  • 3-5年
    32.3% of total 32.3%
  • 不限
    25.8% of total 25.8%
  • 5-10年
    22.6% of total 22.6%
  • 1-3年
    17.7% of total 17.7%
View Detailed Analysis

What does 山东威高血液净化制品股份有限公司 require? Who is 威高血液净化 hiring? 威高血液净化 recruitment: 销售类占比最多占21%,其次是医疗卫生/美容保健类占19.4%. What education can get in at 威高血液净化? 本科占比最多占53.2%,其次是硕士占30.6%. High education required at 威高血液净化? 硕士占30.6%. Work experience required at 威高血液净化? 3-5年占比最多占32.3%,其次是不限占25.8%. Where are the job locations at 威高血液净化? 威海占比最多占67.7%,其次是上海占11.3%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 41,775.4066万(元)
Legal Representative: 宋修山
Date Established:
Credit Code: 91371000769746944L
Registered Address: 威海火炬高技术产业开发区威高西路7号

Talent Demand Trend Analysis More

Partners & Suppliers

费森尤斯委托威高血液净化代工生产透析器 Source
合作客户 透析器OEM合作
供应透析器中空纤维等核心部件 Source
合作客户 透析器核心部件
威高血液净化代理销售日本东丽品牌血液透析器及透析机 Source
供应商 透析产品代理合作
为临泉禾泰肾病专科医院提供透析器、管路等血液透析耗材 Source
合作客户 血液透析耗材
山东威高向百伦透析提供透析器、血路管等耗材,是百伦透析的主要供应商之一。 Source
合作客户 透析设备与耗材

People who follow 威高血液净化 also follow

威高血液净化 Competitors (Similar Companies)

“Trustworthy overall solution provider for medical systems”
“一次性医疗器械”
生产 透析设备 设备 环境管理
条码打印机 智慧金融 智能零售 智慧物流
“Qingfeng people will strive to build Qingfeng into a century-old brand”
风力发电塔 贸易 加工 煤炭设备
制药/药业 医药 生物制品 疫苗
“丰富的骨科系列产品遍布全国各地甲级医院”
“Make thousands of Chinese children healthy and strong”
“Development, production and sales of new energy vehicle and energy sto”
特种车 空港设备 无人机 飞行器
药品零售 零售 零售连锁 药房/药店
医疗器械 无菌医疗器械 无菌注射器 注射器
制药/药业 葡萄糖 甘露醇 山梨醇
西餐 面食 主题餐厅 馅饼

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates